✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Eurofins Scientific SE

Common Name
Eurofins Scientific
Country
Luxembourg
Sector
Healthcare
Industry
Diagnostics & Research
Employees
65,000
Ticker
ERF
Exchange
EURONEXT
Description
Eurofins Scientific SE is a global leader in bioanalytical testing services. Primarily focused on providing testing and laboratory services across diverse fields, Eurofins plays a critical role in ens...

Eurofins Scientific's Financial Statements Preview

Below are the financial statements of Eurofins Scientific, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of EUR
2024 as of 2024-12-31
2023 as of 2023-12-31
Property, plant and equipment
2,559.8a
2,297.4a
Goodwill
4,840.7a
4,551.4a
Other intangible assets
787.8a
796a
Investments in associates
5.9a
5.3a
Non-current financial assets
111.5a
78.3a
Deferred tax assets
130.3a
93.8a
Total non-current assets
8,436.2a
7,822.2a
Inventories
141.9a
139a
Trade receivables
1,094.3a
1,072.8a
Contract assets
306.2a
307.7a
Prepaid expenses and other current assets
192.2a
203.1a
Current income tax assets
101.8a
118.3a
Derivative financial instruments assets
2a
4.3a
Cash and cash equivalents
613.9a
1,221.2a
Total current assets
2,452.2a
3,066.4a
Total assets
10,888.4a
10,888.6a
Share capital
1.9a
1.9a
Treasury shares
-307.8a
-54.9a
Hybrid capital
1,000a
1,000a
Other reserves
1,600.9a
1,600.9a
Retained earnings
2,692.2a
2,393.8a
Currency translation reserve
351.7a
135.8a
Total attributable to owners of the company
5,339a
5,077.5a
Non-controlling interests
45.8a
59.9a
Total shareholders' equity
5,384.7a
5,137.4a
Borrowings
3,131.5a
3,325.6a
Deferred tax liabilities
109.5a
110a
Amounts due for business acquisitions
62.8a
106.8a
Employee benefit obligations
66.4a
66.2a
Provisions
23.2a
20.9a
Total non-current liabilities
3,393.4a
3,629.5a
Borrowings
478.8a
601.1a
Interest due on borrowings and earnings due on hybrid capital
54.7a
59.2a
Trade accounts payable
645.9a
600.2a
Contract liabilities
195.9a
192.8a
Current income tax liabilities
35.5a
26.7a
Amounts due for business acquisitions
45.7a
35.5a
Provisions
32.8a
21.4a
Other current liabilities
621a
584.8a
Total current liabilities
2,110.2a
2,121.7a
Total liabilities and shareholders' equity
10,888.4a
10,888.6a
Limited Data Preview
You are viewing a limited preview of Eurofins Scientific’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Eurofins Scientific’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Eurofins Scientific’s data sources below and access millions more through our Disclosure Search.

a. Eurofins Scientific's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?